Your browser doesn't support javascript.
loading
The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation.
Blaauboer, Amber; van Koetsveld, Peter M; Mustafa, Dana A M; Dumas, Jasper; Dogan, Fadime; van Zwienen, Suzanne; van Eijck, Casper H J; Hofland, Leo J.
Affiliation
  • Blaauboer A; Department of Surgery, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
  • van Koetsveld PM; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
  • Mustafa DAM; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
  • Dumas J; Tumor Immuno-Pathology Laboratory, Department of Pathology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
  • Dogan F; Tumor Immuno-Pathology Laboratory, Department of Pathology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
  • van Zwienen S; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
  • van Eijck CHJ; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
  • Hofland LJ; Department of Surgery, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
Biomedicines ; 10(3)2022 Feb 22.
Article in En | MEDLINE | ID: mdl-35327319
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomedicines Year: 2022 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomedicines Year: 2022 Type: Article Affiliation country: Netherlands